← Every company
Coherus Oncology Inc SEC Filings
What Coherus Oncology Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
CHRS overview →Filings on file
160
since Sep 26, 2016
Warning signs
3
latest Jun 15, 2026
Last results
Aug 5, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Apr 16, 2025 | Tender offer SC TO-I | Read ↗ |
| Apr 14, 2025 | Acquisition or sale completed 8-K | Read ↗ |
| Jan 28, 2025 | Merger vote or registration DEFM14A | Read ↗ |
| Jun 27, 2024 | Acquisition or sale completedMaterial agreement 8-K | Read ↗ |
| Mar 4, 2024 | Debt acceleratedAcquisition or sale completed 8-K | Read ↗ |
| Sep 8, 2023 | Acquisition or sale completed 8-K | Read ↗ |
| Jul 7, 2023 | Merger vote or registration S-4 | Read ↗ |
Source: Coherus Oncology Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on CHRS
Company overviewEverything on CHRS in one place, with the price.Executive payWhat CHRS awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in CHRS.Funds holding itWhich funds and ETFs hold CHRS, and how big a bet.PatentsWhat CHRS is filing at the patent office.